Historical record - last NADAC effective date: 5/22/2024
Product Information
DOXEPIN 10 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.0738 per EA under NDC 69315015801. Its NADAC has been published 56 times since May 10, 2023.
FDA first approved this application on Mar 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315015801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/22/2024
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211619FDA Approved
3/9/2021
TE Code
AB
On Market Since
4/15/2021
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 10 MG CAPSULE has been published 56 times since May 10, 2023, and over the history we have for it it has declined 31.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0738 per EA |
|---|---|
| All-time high | $0.1473 (Sep 13, 2023) |
| All-time low | $0.0738 (May 22, 2024) |
| Median price | $0.1090 |
| Average price | $0.1156 |
| Largest weekly change | +40.1% (Mar 20, 2024) |
| Weeks tracked | 56 |
| Tracking since | May 10, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-38.6%
5Y
N/A
All
-31.8%
Last surveyed May 29, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 10 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.0738 per EA (NDC 69315015801), effective May 29, 2024.
How has the price of DOXEPIN 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 10 MG CAPSULE has declined 31.8%. It has been tracked across 56 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for DOXEPIN 10 MG CAPSULE?
Since May 10, 2023, the NADAC for DOXEPIN 10 MG CAPSULE has ranged from a low of $0.0738 (May 22, 2024) to a high of $0.1473 (Sep 13, 2023), with a median of $0.1090 per EA.
Are there cheaper alternatives to DOXEPIN 10 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXEPIN 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN 10 MG CAPSULE?
DOXEPIN 10 MG CAPSULE (NDC 69315015801) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.